Non-Accredited Satellite Symposia

 

Title: TBD
Saturday, October 12 | 6 – 9 p.m.
Place: TBD
Presented by: Octapharma, Annual Meeting Supporter
 
Brief program description:  TBD

Speakers: TBD

Register: link to register is coming soon 

 

Pressure & Flow: Preventing & Treating Intraoperative Hypotension
Saturday, October 13 | Noon – 1 p.m. 
Moscone Center South, Level 3, Room 305-314
Presented by: Edwards Lifesciences, Industry Supporter
 
Though intraoperative hypotension is common in surgical patients, numerous studies now indicate that it is strongly associated with risk. Avoidance of hypotension and strategies to optimize fluid management in surgical patients are two modifiable factors that may contribute to improved patient outcomes. “Prompt treatment of intraoperative hypotension is more likely to improve patient outcome if the treatment is consistent with the underlying mechanism of hypotension.” This Satellite Symposium will review the clinical implications of intraoperative hypotension and strategies to reduce associated risk.

Speakers: 
Dr. Timothy Miller, Duke University Hospital, Durham, NC
Dr. Kamal Maheshwari, Cleveland Clinic, Cleveland, OH
Dr. Simon Davies, York Teaching Hospitals, York UK

Register Here


Advancements in noninvasive clinical monitoring for real-time visibility of patient status
Saturday, October 13 | 12 p.m. - 1 p.m.
Moscone Center South, Upper Mezzanine, Esplanade Ballroom
Presented by: Masimo, Industry Supporter

Speakers: 
Andre Denault, MD, PhD, ABIM-CCM, FRCPC, FASE, FCCS
Department of Anesthesiology, Critical Care Program, Montreal Heart Institute, and Centre Hospitalier de l’Université de Montréal, Université de Montréal, Montreal, Quebec, Canada

Maxime Cannesson, MD, PhD
Professor of Anesthesiology & Vice Chair for Perioperative Medicine,
University of California Los Angeles, Los Angeles, California, USA
Description:
Recent advances in noninvasive monitoring can have a significant impact on anesthesia practices.  These innovative technology platforms can help facilitate timelier assessment of patient status and streamline clinical workflows through flexible integration into multi-parameter monitors.
 
Objectives:
Discover how an integrated monitoring approach provides anesthesiologists with additional clinical insight.
Recognize the value of simultaneously using multiple parameters during perioperative care, such as noninvasive continuous hemoglobin, pleth variability, and brain monitoring.
Understand the role of bedside ultrasound in the management of brain and somatic desaturation.
Learn how to incorporate CNS monitoring parameters with processed EEG data during the care of patients under anesthesia. 

Register: link to register is coming soon

 

PONV: Current and Future Management Strategies in the Surgical Patient
Saturday, October 13, 5:30 – 8:30 p.m.
W Hotel, Great Room 2, Level 3
Presented by: Acacia Pharmaceuticals, Annual Meeting Supporter
 
Postoperative nausea and vomiting (PONV) remains a common problem in the management of patients undergoing a wide variety of surgical procedures. PONV occurs in 10% to 20% of patients with zero or one risk factor and can run as high as 40% to 80% of patients with two or more risk factors. The consequences of PONV are far reaching—ranging from reduced patient satisfaction levels to potentially more serious medical complications that may impact surgical outcomes and increase costs. It is important for anesthesiologists and other members of the surgical team to understand not only the incidence and etiology of PONV, but the risk factors, risk stratification strategies, and current management approaches—to better predict which patients would benefit most from medical intervention to optimize outcomes. This program is designed to provide attendees with practical strategies for the management of PONV as well as a review of recent clinical trial data in prophylaxis and treatment.

Speakers: 
Chair:
Tong Joo (TJ) Gan, M.D., MHS, FRCA, MBA, Professor and Chairman of the Department of Anesthesiology, Stony Brook School of Medicine

Faculty:
Sabry Ayad, M.D., Anesthesiologist, Cleveland Clinic
Ashraf Samir Habib, MB, BCh, Professor of Anesthesiology, Duke University School of Medicine
Anthony L. Kovac, Jr. M.D., Professor, Vice Chairman of Research, University of Kansas Medical Center 

Register: link to register is coming soon


Title: TBD
Sunday, October 14 | Noon – 1 p.m. 
Moscone Center, Level 2, Room 206-216
Presented by: ePreop, Industry Supporter
 
Brief program description:  TBD

Speakers: TBD

Register: link to register is coming soon


Scarcity of Critical Perioperative Drugs
Sunday, October 14 | Noon – 1 p.m.
Moscone Center South, Upper Mezzanine, Esplanade Ballroom 
Presented by: Fresenius Kabi, Industry Supporter
 
Drug shortages continue to be a challenge for many anesthesia providers. This program will address the impact of drug shortages on the perioperative process, current strategies to avoid compromising patient care, and potential long-term solutions. A national perspective on how ASA, FDA and the pharma industry are working together to mitigate these issues will also be shared.

Speakers:
Edward R. Mariano, M.D., M.A.S., Chief, Anesthesiology and Perioperative Care Service and Associate Chief of Staff for Inpatient Surgical Services, VA Palo Alto Health Care System and Professor of Anesthesiology, Perioperative and Pain Medicine, Stanford University School of Medicine

Val Jensen, R.Ph., Associate Director, CDER Drug Shortage Staff, FDA

Register: link to register is coming soon


Title: TBD
Sunday, October 14 | Noon – 1 p.m.
Moscone Center, Level 3, Room 305-314
Presented by: Mallinckrodt, Industry Supporter
 
Brief program description: TBD 

Speakers: TBD

Register: link to register is coming soon


Fast Track Spinal Anesthesia: A New Kid in Town
Sunday, October 14 | 6 – 9 p.m.
InterContinental Hotel, Grand Ballroom, Level 3
Presented by: B. Braun, Annual Meeting Supporter
 
Preservative free 1% 2-Chloroprocaine has been recently approved by the FDA for intratechal injection for the production of subarachnoid block (spinal anesthesia) in adults undergoing surgical procedures.  Indicated procedures for those suitable for short duration of action.  Clorotekal® (1% Chloroprocaine HCL) is a local anesthetic with a very short half-life and a favorable evolution of spinal block for ultra-short outpatient procedures with a very low risk of urinary retention and transient neurological symptoms. 

Speakers:
Narinder Rawel, M.D., Professor, Department of Anaesthesiology and Intensive Care, Orebro University, Orebro, Sweden
Arthur Atchabahian, M.D., New York University School of Medicine, New York, NY
Julia Pollock, M.D., Virginia Mason Medical Center, Seattle, WA
Marc Schmittner, DESA, M.H.B.A., Prof. DM Director of the Department of Anaesthesiology, Intensive Care and Pain Medicine, Unfallkrankenhaus, Berlin, Germany

Register: link to register is coming soon


Recent Advances in Ambulatory Surgery Analgesia
Monday, October 15 | 6 – 8 a.m.
W Hotel, Great Room 1, Level 3
Presented by: AcelRx Pharmaceuticals, Annual Meeting Supporter
 
Sufentanil Sublingual Tablet 30 mcg (DSUVIATM) is in development for the treatment of moderate- to severe-acute pain in adult patients in a medically supervised setting. The unique route of administration and PK/PD profile potentially allow DSUVIA to be a viable analgesic option in short-term settings, such as following ambulatory surgery.

Speaker: 
Leo Rodriguez, M.D., Envision Physician Services

Register: link to register is coming soon


Clinical Considerations in Neuromuscular Blockade Management 
Monday, October 15 | Noon – 1 p.m. 
Moscone Center South, Upper Mezzanine, Esplanade Ballroom
Presented by: Merck & Co, Industry Supporter
 
This symposium will discuss the clinical rationale and society guidelines related to monitoring neuromuscular blockade and recovery.  It will also include clinical data for an FDA-approved agent that reverses moderate and deep neuromuscular blockade.

Learning Objectives: 

1.  Understand the importance of monitoring neuromuscular blockade and recovery
2.  Review clinical data for neuromuscular blockade management

Speaker:
Alan D. Kaye, M.D., Ph.D., DABA, DABPM, DABIPP, Chair, Department of Anesthesiology, Louisiana State University Health 

Merck is pleased to sponsor this program to provide information consistent with FDA guidelines. This program is not an accredited CME program and is not designed to meet any training and/or educational requirements. This medical education program for U.S. health care professionals and health care business professionals only. The speaker for this program is speaking on behalf of Merck.

Register: link to register is coming soon


Title: TBD
Monday, October 15 | Noon – 1 p.m. 
Moscone Center, Level 2, Room 206-216
Presented by: PharMEDium, Industry Supporter
 
Brief program description: TBD

Speakers: TBD

Register: link to register is coming soon

 

 

Helpful Information

 

Register now  arrow

 

ASA Membership Matters

ASA members receive deep discounts on registration. Join today!

 

Thank You Industry Supporters

Whose contributions allow the American Society of Anesthesiologists® to create world-class education and resources to improve patient care and outcomes.

 

ASA Industry Supporters

 

 

Thank You Annual Meeting Supporters

 

ASA Industry Supporters